DGX - QUEST DIAGNOSTICS INC


196.27
-3.260   -1.661%

Share volume: 1,038,852
Last Updated: 04-24-2026
Healthcare/Services – Health: 0.01%

PREVIOUS CLOSE
CHG
CHG%

$199.53
-3.26
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
55%
Profitability 46%
Dept financing 36%
Liquidity 67%
Performance 65%
Company vs Stock growth
vs
Performance
5 Days
-3.79%
1 Month
0.39%
3 Months
6.53%
6 Months
8.88%
1 Year
11.09%
2 Year
40.70%
Key data
Stock price
$196.27
P/E Ratio 
20.94
DAY RANGE
$194.46 - $200.07
EPS 
$9.17
52 WEEK RANGE
$164.65 - $213.50
52 WEEK CHANGE
$11.09
MARKET CAP 
21.438 B
YIELD 
1.64%
SHARES OUTSTANDING 
110.696 M
DIVIDEND
$0.86
EX-DIVIDEND DATE
04-06-2026
NEXT EARNINGS DATE
07-22-2025
BETA 
0.29
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,550,356
AVERAGE 30 VOLUME 
$1,060,115
Company detail
CEO: James E. Davis
Region: US
Website: questdiagnostics.com
Employees: 49,000
IPO year: 1996
Issue type: Common Stock
Market: NYSE
Industry: Healthcare/Services – Health
Sector: Services

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic info services. It also provides risk assessment services for life insurance industry; and healthcare organizations and clinicians robust information technology solutions.

Recent news